30-Second Takeaway
- High physician-level antibiotic use for AECOPD without pneumonia did not improve mortality, ICU transfer, readmission, or LOS.
- Transcriptomic lung maps in COPD and ILD highlight discrete pathogenic niches that may yield future biomarkers and drug targets.
- In ILD patients ≥75 years, transbronchial cryobiopsy showed high diagnostic yield with acceptable severe complication rates.
- Simple tools—PEEP titration frameworks, Prognostic Nutritional Index in PE, and RT-led sleep clinics—can refine risk and extend capacity.
- Pulmonary nodules are common while RSV testing is rare in adult LRTI and exacerbations, reshaping expectations for imaging and diagnostics.
Week ending January 31, 2026
Pulmonary practice updates: antibiotics in AECOPD, ARDS PEEP titration, ILD tools, nodules, PE risk, sleep care models, and RSV testing
Higher antibiotic use in AECOPD without pneumonia offers no measurable clinical benefit
This multicenter retrospective cohort included 2,043 hospitalizations for AECOPD without radiographic pneumonia, managed by 106 general medicine physicians. Overall, 52.1% of patients received antibiotics, but physician prescribing propensity ranged widely from 15.2% to 96.2%. Higher physician antibiotic propensity was not associated with lower in-hospital mortality, ICU transfer, 30-day readmission, or shorter LOS after adjustment. These data undermine routine inpatient antibiotics for AECOPD without pneumonia and support standardized stewardship protocols.
Single-nucleus lung atlas links specific cell states to COPD severity and emphysema
Investigators profiled 1,516,727 lung nuclei from 141 participants using single-nucleus RNA sequencing, integrating lung function, emphysema, and composite symptom scores. Early COPD showed expansion of epithelial regenerative states, which later declined as inflamed nonimmune and profibrotic/remodeling states expanded. Spatial transcriptomics revealed localized niches where pathologic epithelial and immune populations co-occurred, correlating with emphysema and physiological impairment. Plasma proteomics identified circulating biomarkers reflecting these cell states and extracellular matrix remodeling, suggesting translational diagnostic and therapeutic targets.
Spatial mapping identifies epithelial–fibroblast niches and key drivers of lung fibrosis
Using single-nucleus RNA sequencing and spatial transcriptomics, this study mapped distal lung cellular networks and their alterations in fibrotic interstitial lung disease. Transition from normal parenchyma to fibrosis featured ectopic bronchiolization and decellularization, with active lesions showing co-localized CTHRC1-high fibroblasts and aberrant transitional epithelium. Organoid models demonstrated that combined TGF-β, IL-1β, and TNF-α exposure was required to induce the pathogenic transitional epithelial state. NFATC4 was necessary for myofibroblast differentiation driven by soluble mediators or mechanosensing, highlighting a potential antifibrotic target.
Narrative review summarizes physiologic and imaging-based approaches to PEEP titration in ARDS
This narrative review outlines contemporary strategies for PEEP titration in ARDS, emphasizing heterogeneity of lung injury and regional mechanics. Oxygenation-based titration remains common but risks overlooking overdistension and regional derecruitment. Alternative approaches include compliance-guided methods, driving-pressure minimization, and oesophageal pressure-guided ventilation, each with physiologic appeal but limited validation. Imaging tools—CT, electrical impedance tomography, lung ultrasound, and radiography—help assess recruitability and refine individualized PEEP settings.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.